KPIs & Operating Metrics(New)
Growth Metrics

Arcosa (ACA) Capital Expenditures (2017 - 2026)

Arcosa's Capital Expenditures history spans 10 years, with the latest figure at $43.5 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 31.82% to $43.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $176.1 million, a 4.63% increase, with the full-year FY2025 number at $165.6 million, down 12.7% from a year prior.
  • Capital Expenditures hit $43.5 million in Q1 2026 for Arcosa, down from $64.2 million in the prior quarter.
  • Over the last five years, Capital Expenditures for ACA hit a ceiling of $64.2 million in Q4 2025 and a floor of $25.9 million in Q1 2022.
  • Historically, Capital Expenditures has averaged $43.5 million across 5 years, with a median of $44.4 million in 2023.
  • Biggest five-year swings in Capital Expenditures: soared 114.4% in 2022 and later plummeted 39.5% in 2025.
  • Tracing ACA's Capital Expenditures over 5 years: stood at $52.1 million in 2022, then grew by 12.67% to $58.7 million in 2023, then dropped by 9.2% to $53.3 million in 2024, then increased by 20.45% to $64.2 million in 2025, then plummeted by 32.24% to $43.5 million in 2026.
  • Business Quant data shows Capital Expenditures for ACA at $43.5 million in Q1 2026, $64.2 million in Q4 2025, and $39.6 million in Q3 2025.